Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hanover Bancorp, Inc. /MDHNVR · Entity 1705 | President | February 20, 2026 | February 24, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hanover Bancorp, Inc. /MD
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 97,697 |
Ending reported balance
After 2026-02-20 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2026-02-20 · Tax withholding · Disposed 421 · Balance 100,677 F1: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 29, 2025. Row 2 · 2026-02-20 · Tax withholding · Disposed 536 · Balance 100,141 F2: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023. Row 3 · 2026-02-20 · Tax withholding · Disposed 624 · Balance 99,517 F3: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 19, 2024. Row 4 · 2026-02-20 · Tax withholding · Disposed 1,820 · Balance 97,697 F4: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 29, 2025.
F2: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023.
F3: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 19, 2024.
F4: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 20, 2026 Filed Feb 24, 2026 13:35 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 1,820 | $21.98 | $40,003.60 |
DisclosureSEC source: 0001225208-26-002440 · doc4.xml · nonDerivative · entry 4 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,697 F4 · shares: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 13:35 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 624 | $21.98 | $13,715.52 |
DisclosureSEC source: 0001225208-26-002440 · doc4.xml · nonDerivative · entry 3 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 99,517 F3 · shares: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 19, 2024. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 13:35 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 536 | $21.98 | $11,781.28 |
DisclosureSEC source: 0001225208-26-002440 · doc4.xml · nonDerivative · entry 2 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,141 F2 · shares: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 13:35 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 421 | $21.98 | $9,253.58 |
DisclosureSEC source: 0001225208-26-002440 · doc4.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,677 F1 · shares: Reflects tax withholding on February 20, 2026 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 29, 2025. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 19:46 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 6,125 | $22.65 | $138,731.25 |
DisclosureSEC source: 0001619964-25-000026 · primary_doc.xml · nonDerivative · entry 2 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,098 F2 · shares: Reflects tax withholding of shares acquired pursuant to performance units reported in the immediately preceding line. Read SEC document |
| March 31, 2025 Filed Apr 1, 2025 19:46 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | GrantCommon Stock | 11,076 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-25-000026 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,223 F1 · shares: Shares acquired pursuant to earned performance units granted on January 27, 2022. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 17:57 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 856 | $25.53 | $21,853.68 |
DisclosureSEC source: 0001619964-25-000023 · primary_doc.xml · nonDerivative · entry 3 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 96,147 F3 · shares: Reflects tax withholding on February 20, 2025 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 19, 2024. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 17:57 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 731 | $25.53 | $18,662.43 |
DisclosureSEC source: 0001619964-25-000023 · primary_doc.xml · nonDerivative · entry 2 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,003 F2 · shares: Reflects tax withholding on February 20, 2025 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 17:57 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 3,363 | $25.53 | $85,857.39 |
DisclosureSEC source: 0001619964-25-000023 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 97,734 F1 · shares: Reflects tax withholding on February 20, 2025 with respect to restricted shares vested on the same date, pursuant to grants of restricted stock on January 27, 2022. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 14:44 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Exercise / conversionNon-Qualified Stock Option · Derivative | 42,000 | $0.00 Strike: $6.25 | $0.00 |
DisclosureSEC source: 0001619964-25-000018 · primary_doc.xml · derivative · entry 3 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 42,000 shares Expires 2025-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 14:44 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 27,668 | $26.41 | $730,711.88 |
DisclosureSEC source: 0001619964-25-000018 · primary_doc.xml · nonDerivative · entry 2 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 101,097 Read SEC document |
| February 06, 2025 Filed Feb 7, 2025 14:44 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Exercise / conversionCommon Stock | 42,000 | $6.25 | $262,500.00 |
DisclosureSEC source: 0001619964-25-000018 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,765 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 29, 2025 Filed Jan 31, 2025 18:36 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | GrantCommon Stock | 5,228 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-25-000009 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,765 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2026, February 20, 2027, February 20, 2028, February 20, 2029, and February 20, 2030. Read SEC document |
| April 30, 2024 Filed May 1, 2024 15:19 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | PurchaseCommon Stock | 250 | $16.60 | $4,150.00 |
DisclosureSEC source: 0001619964-24-000029 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,537 Read SEC document |
| April 22, 2024 Filed Apr 23, 2024 16:30 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | PurchaseCommon Stock | 200 | $16.91 | $3,382.00 |
DisclosureSEC source: 0001619964-24-000022 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,287 Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 20:23 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 532 | $17.60 | $9,363.20 |
DisclosureSEC source: 0001619964-24-000010 · primary_doc.xml · nonDerivative · entry 2 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,087 F2 · shares: Reflects tax withholding on February 20, 2024 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 24, 2023. Read SEC document |
| February 20, 2024 Filed Feb 22, 2024 20:23 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 2,442 | $17.60 | $42,979.20 |
DisclosureSEC source: 0001619964-24-000010 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,619 F1 · shares: Reflects tax withholding on February 20, 2024 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. Read SEC document |
| January 19, 2024 Filed Jan 23, 2024 16:24 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | GrantCommon Stock | 7,745 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-24-000002 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,061 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2025, February 20, 2026, February 20, 2027, February 20, 2028 and February 20, 2029. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 20:01 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Exercise / conversionNon-Qualified Stock Option · Derivative | 29,900 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001619964-23-000027 · primary_doc.xml · derivative · entry 3 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,900 shares Expires 2024-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 20:01 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 18,783 | $17.40 | $326,824.20 |
DisclosureSEC source: 0001619964-23-000027 · primary_doc.xml · nonDerivative · entry 2 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,316 Read SEC document |
| December 26, 2023 Filed Dec 28, 2023 20:01 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Exercise / conversionCommon Stock | 29,900 | $4.46 | $133,354.00 |
DisclosureSEC source: 0001619964-23-000027 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2023 Filed Feb 23, 2023 02:29 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | Tax withholdingCommon Stock | 842 | $19.56 | $16,469.52 |
DisclosureSEC source: 0001619964-23-000018 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · SEVP, C.Lending & Revenue Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,199 F1 · shares: Reflects tax withholding on February 20, 2023 with respect to restricted shares vested on the same date, pursuant a grant of restricted stock on January 27, 2022. Read SEC document |
| January 24, 2023 Filed Jan 26, 2023 19:28 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | GrantCommon Stock | 6,612 | $0.00 | $0.00 |
DisclosureSEC source: 0001619964-23-000003 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · SEVP, C.Lending & Revenue Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,041 F1 · shares: Represents a grant of restricted stock subject to forfeiture, vesting over a five year period, with 1/5 vesting on each of February 20, 2024, February 20, 2025, February 20, 2026, February 20, 2027, and February 20, 2028. Read SEC document |
| May 11, 2022 Filed May 11, 2022 16:16 UTC | Hanover Bancorp, Inc. /MD HNVR · Entity 1705 | PurchaseCommon Stock | 5,000 | $21.00 | $105,000.00 |
DisclosureSEC source: 0001619964-22-000031 · primary_doc.xml · nonDerivative · entry 1 Wilcox McClelland W · CIK 0001913286 · SEVP, C.Lending & Revenue Off. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,429 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.